Revenue | ₹7.87Cr |
Net Profits | ₹-75.85Cr |
Net Profit Margins | -963.79% |
Sun Pharma Advanced Research Company Ltd’s revenue fell -38.99% since last year same period to ₹7.87Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -58.09% fall in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit jumped 29.33% since last year same period to ₹-75.85Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -46.23% fall in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin fell -15.84% since last year same period to -963.79% in the Q2 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -248.95% fall in its net profit margins since last 3-months.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q2 results 2025 was ₹7.87Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q2 results 2025 was ₹-75.85Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q2 results 2025 was -963.79%.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q2 results 2024 was ₹12.90Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q2 results 2024 was ₹-107.33Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q2 results 2024 was -832.02%.